1,551 research outputs found

    ์‹ํ’ˆ ๋‚ด ๋ณ‘์›์„ฑ ๋Œ€์žฅ๊ท  O157:H7์˜ ๊ฒ€์ถœ์„ ์œ„ํ•œ ์••ํƒ€๋จธ ๊ธฐ๋ฐ˜์˜ ์ด์ค‘๊ธฐ๋Šฅ๋ง์ปค ๊ฐœ๋ฐœ ๋ฐ ๊ธˆ ๋‚˜๋…ธ์ž…์ž ์‘์ง‘ ๊ธฐ๋ฐ˜ ๋น„์ƒ‰ ์–ด์„ธ์ด ๊ฐœ๋ฐœ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ๋†์—…์ƒ๋ช…๊ณผํ•™๋Œ€ํ•™ ๋†์ƒ๋ช…๊ณตํ•™๋ถ€, 2023. 2. ์ตœ์˜์ง„.In this study, we developed a colorimetric assay with bi-functional gold nanoparticle (AuNP) based on aptamer for sensitive detection of Escherichia coli O157:H7 using the aggregation of AuNP linked with a complementary DNA aptamer specific to E. coli O157:H7 aptamer. AuNP was used as a colorimetric linker and probe, respectively, and E. coli O157:H7 aptamer and its complementary DNA sequences were modified on each AuNP surface. AuNP labeled with E. coli O157:H7 aptamer was used as a bi-functional linker (BL) in a colorimetric competitive assay. Colorimetric assay with BL based on aptamer detected target bacteria by sequential competitive binding between colorimetric probes, which are AuNP having complementary sequences of E. coli O157:H7 (AA, Aggregation Assistant) and E. coli O157:H7 aptamer. In addition, under optimized conditions by main testing parameters, the assay exhibited a detection range of 101 to 106 CFU/400 ยตL and a detection limit of 57 ยฑ 0.5 CFU/400 ยตL. In addition, the developed colorimetric assay with BL based on aptamer was excellently evaluated as an on/off detection system in coconut water, a real matrix. Thus, the proposed colorimetric competitive assay with BL based on aptamer can be a proper on-site detection method of foodborne pathogens. In addition, this study provides the basis for research into developing different colorimetric assay with aptamer for pathogen analysis in real matrices. This colorimetric assay with BL based on aptamer functions by driving the system between two competitive interaction dynamics: A) affinity between the aptamer sequence and the target, and B) affinity between the aptamer and the its complementary DNA aptamer.์ด ์—ฐ๊ตฌ์—์„œ ์šฐ๋ฆฌ๋Š” E. coli O157์— ํŠน์ด์ ์ธ ์••ํƒ€๋จธ์™€ ์ƒ๋ณด์  DNA ์••ํƒ€๋จธ๊ฐ€ ๊ฒฐํ•ฉ๋œ AuNP์˜ ์‘์ง‘์— ๊ธฐ์ดˆํ•˜์—ฌ E. coli O157:H7์˜ ํ˜„์žฅ์—์„œ ์‹ ์†ํ•˜๋ฉฐ ๋ฏผ๊ฐํ•˜๊ฒŒ ๊ฒ€์ถœํ•  ์ˆ˜ ์žˆ๋Š”, ์••ํƒ€๋จธ๊ฐ€ ๊ฒฐํ•ฉ๋œ ์ด์ค‘ ๊ธฐ๋Šฅ๋ง์ปค AuNP๋ฅผ ์ด์šฉํ•œ ๋น„์ƒ‰ ๊ฒ€์ถœ๋ฒ•์„ ๊ฐœ๋ฐœํ•˜์˜€๋‹ค. ์ด ์‹œ์Šคํ…œ์—์„œ AuNP๋Š” ์ด์ค‘๊ธฐ๋Šฅ๋ง์ปค ๋ฐ ์‘์ง‘๋ณด์กฐ ํ”„๋กœ๋ธŒ๋กœ ์‚ฌ์šฉ๋˜์—ˆ์œผ๋ฉฐ, ๊ฐ AuNP ํ‘œ๋ฉด์€ E. coli O157:H7 ๋Œ€์ƒ ์••ํƒ€๋จธ์™€ ์ƒ๋ณด์ ์ธ DNA ์„œ์—ด์˜ ์••ํƒ€๋จธ๋กœ ๊ฒฐํ•ฉ๋˜์—ˆ์œผ๋ฉฐ, ์ด๋Š” ๊ฐ๊ฐ ์ด์ค‘๊ธฐ๋Šฅ๋ง์ปค AuNP (BL)์™€ ์‘์ง‘๋ณด์กฐ ํ”„๋กœ๋ธŒ AuNP (AA)๋กœ ๋ช…๋ช…ํ•˜์˜€๋‹ค. BL์€ ๋Œ€์ƒ๊ท ์ด ์กด์žฌํ•˜์ง€ ์•Š์„ ๋•Œ์—๋Š” ์ƒ๋ณด์ ์ธ ์„œ์—ด์— ์˜ํ•ด AA์™€ ๊ฒฐํ•ฉํ•˜์˜€์œผ๋ฉฐ, ์–‘์ ๊ท ํ˜•์— ์˜ํ•ด ํŠน์ •์˜์—ญ(REVC, 120 โ€“ 220 ฮผL)์—์„œ ์‘์ง‘ ๋ฐ ์นจ์ „์ด ์ผ์–ด๋‚ฌ๋‹ค. ํ•˜์ง€๋งŒ, ๋Œ€์ƒ๊ท ์ด ํˆฌ์ž…๋˜์—ˆ์„ ๋•Œ์—๋Š” ๊ฒฝ์Ÿ์  ๊ฒฐํ•ฉ ์šฐ์„ ์ˆœ์œ„์— ์˜ํ•ด ์ƒ๋ณด์  ์„œ์—ด์˜ AA๊ฐ€ ์•„๋‹ˆ๋ผ ๋Œ€์ƒ๊ท ์ธ E. coli O157:H7๊ณผ ๊ฒฐํ•ฉํ•˜๊ฒŒ ๋œ๋‹ค. ์ด๋Š” ๊ธฐ์กด์˜ ์–‘์ ๊ท ํ˜•์—์„œ์˜ ์ฐจ์ด๋ฅผ ์ผ์œผํ‚ค๊ฒŒ ๋˜๊ณ  ๋Œ€์กฐ๊ตฐ๊ณผ ์œ ์‚ฌํ•œ ์‘์ง‘ ๋ฐ ์นจ์ „์ด ์ผ์–ด๋‚˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ๊ธฐ์กด๋ณด๋‹ค ๋” ๋งŽ์€ ์–‘์˜ BL์ด ๋ฐ˜์‘์— ์ฐธ์—ฌํ•˜์—ฌ์•ผ ํ•œ๋‹ค. ์ด๋ฅผ ํ†ตํ•ด ๋Œ€์กฐ๊ตฐ๊ณผ ๋Œ€์ƒ๊ท  ๊ฐ„์—๋Š” REVC ์˜์—ญ์˜ ๋ณ€ํ™”๊ฐ€ ๋ฐœ์ƒํ•˜๊ฒŒ ๋˜๋ฉฐ, ์ด๋ฅผ ํ†ตํ•ด ๋Œ€์ƒ๊ท ์˜ ์œ ๋ฌด๋ฅผ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๊ฒ€์ถœ์€ ๊ฐ€์žฅ ๋ฏผ๊ฐํ•˜๋ฉฐ ๊ตฌ๋ถ„๋˜๋Š” BL ์˜์—ญ์ธ 100, 120, 140 ฮผL์—์„œ ์ง„ํ–‰๋˜์—ˆ์œผ๋ฉฐ, ์ตœ์ ํ™”๋œ ์กฐ๊ฑด์—์„œ 101 ~ 106 CFU/400 ฮผL์˜ ๊ฒ€์ถœ ๋ฒ”์œ„์™€ 57 ยฑ 0.5 CFU/400 L์˜ ๊ฒ€์ถœ ํ•œ๊ณ„๋ฅผ ๋‚˜ํƒ€๋ƒˆ๋‹ค. ๋˜ํ•œ ์••ํƒ€๋จธ ๊ธฐ๋ฐ˜์˜ BL์„ ์ด์šฉํ•œ ๋น„์ƒ‰๋ถ„์„๋ฒ•์€ ์‹ค์ œ ๋งคํŠธ๋ฆญ์Šค์ธ ์ฝ”์ฝ”๋„›์›Œํ„ฐ์—์„œ๋„ on/off ๊ฐ์ง€ ์‹œ์Šคํ…œ์œผ๋กœ ๋งค์šฐ ์šฐ์ˆ˜ํ•˜๊ฒŒ ํ‰๊ฐ€๋˜์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ ์ œ์•ˆ๋œ ์••ํƒ€๋จธ ๊ธฐ๋ฐ˜์˜ BL์„ ์ด์šฉํ•œ ๋น„์ƒ‰๋ถ„์„๋ฒ•์€ ์‹์ค‘๋…์„ ์ผ์œผํ‚ค๋Š” ๋ณ‘์›์ฒด๋ฅผ ํ˜„์žฅ์—์„œ ๊ฒ€์ถœํ•˜๋Š” ๋ฐ ์ ํ•ฉํ•œ ๋ฐฉ๋ฒ•์ด ๋  ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ๊ธฐ๋Œ€๋œ๋‹ค. ๋˜ํ•œ, ๋ณธ ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•ด ์‹ค์ œ ๋งคํŠธ๋ฆญ์Šค์—์„œ ๋ณ‘์›๊ท  ๋ถ„์„์„ ์œ„ํ•œ ์•ฑํƒ€๋จธ ๊ธฐ๋ฐ˜ ๋น„์ƒ‰ ๋ถ„์„ ๊ฐœ๋ฐœ์— ๋Œ€ํ•œ ํ–ฅํ›„ ์—ฐ๊ตฌ์˜ ๊ธฐ๋ฐ˜์„ ์ œ๊ณตํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ด ์••ํƒ€๋จธ ๊ธฐ๋ฐ˜ ๋น„์ƒ‰ ๋ถ„์„๋ฒ•์€ A) ์••ํƒ€๋จธ ์„œ์—ด๊ณผ ํ‘œ์  ์‚ฌ์ด์˜ ์นœํ™”์„ฑ, B) ์••ํƒ€๋จธ์™€ ๊ทธ ์ƒ๋ณด์ ์ธ DNA ์••ํƒ€๋จธ ์‚ฌ์ด์˜ ์นœํ™”๋ ฅ์ด๋ผ๋Š” ๋‘ ๊ฐ€์ง€ ๊ฒฝ์Ÿ์ ์ธ ์ƒํ˜ธ ์ž‘์šฉ ์—ญํ•™์— ์˜ํ•ด ๊ตฌ๋™๋˜์—ˆ๋‹ค.โ… . INTRODUCTION ๏ผ‘ โ…ก. MATERIALS AND METHODS 5 2.1. Materials 5 2.2. Instrumentation 5 2.3. Culturing of Bacteria 6 2.4. Preparation of gold nanoparticles (AuNP) 6 2.5. Modification of AuNP with aptamer 7 2.6. Optimization of NaCl concentrations 8 2.7. Detection of E. coli O157:H7 in samples 8 2.8. Verification of the selectivity of the detection method 9 2.9. Statistical analysis 10 โ…ข. RESULTS AND DISCUSSION 11 3.1. Overall detection procedures 11 3.2. Optimization of NaCl concentrations 17 3.3. Selectivity of the colorimetric assay 25 3.4. The range of REVC 27 3.5. Detection of E. coli O157:H7 in HEPES buffer 29 3.6. Detection of E. coli O157:H7 in coconut water 34 CONCLUSION 39 REFERENCES 41 ๊ตญ๋ฌธ์ดˆ๋ก 45์„

    Is the Direct Fixation of Displaced Quadrilateral Plates in Acetabular Fractures Necessary?

    Get PDF
    Quadrilateral plate fractures represent a heterogeneous group of acetabular fractures. Accurate reduction is required to prevent post-traumatic arthritis. The purpose of this study is to determine the reduction effect of the direct fixation of quadrilateral plates in acetabular fractures, and to evaluate the strength of direct fixation compared to indirect fixation. Between 2005 and 2021, 49 patients underwent surgery for open reduction and internal fixation in acetabular fractures with severely displaced quadrilateral plates. Twenty-nine patients comprised the indirect fixation group, and twenty patients comprised the direct fixation group. In a comparison of primary outcome between two groups, 10 out of 29 indirect-group patients and 1 out of 20 direct-group patients developed post-traumatic osteoarthritis, wherein the difference between the two groups is statistically significant. In the assessment of postoperative Matta\u27s radiological reduction status, 19 out of 20 patients in the direct group had achieved anatomical and congruent reduction. The treatment using a direct reduction and internal fixation improved the reduction quality of articular displacement and offered a better survivorship of the affected hip joint

    Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome

    Get PDF
    PurposeTo investigate the efficacy of topiramate monotherapy in West syndrome prospectively.MethodsThe study population included 28 patients (15 male and 13 female children aged 2 to 18 months) diagnosed with West syndrome. After a 2-week baseline period for documentation of the frequency of spasms, topiramate was initiated at 2 mg/kg/day. The dose was increased by 2 mg/kg every week to a maximum of 12 mg/kg/day. Clinical assessment was based on the parents' report and a neurological examination every 2 weeks for the first 2 months of treatment. The baseline electroencephalograms (EEGs) were compared with the post-treatment EEGs at 2 weeks and 1 month.ResultsWest syndrome was considered to be cryptogenic in 7 of the 28 patients and symptomatic in 21 patients. After treatment, 11 patients (39%) became spasm-free, 6 (21%) had more than 50% spasmsreduction, 3 (11%) showed less than 50% reduction, and 8 (29%) did not respond. The effective daily dose for achieving more than 50% reduction in spasm frequency, including becoming spasm-free, was found to be 5.8ยฑ1.1 mg/kg/day. Nine patients (32%) showed complete disappearance of spasms and hypsarrhythmia, and 11 (39%) showed improved EEG results. Despite adverse events (4 instances of irritability, 3 of drowsiness, and 1 of decreased feeding), no patients discontinued the medication.ConclusionTopiramate monotherapy seems to be effective and well tolerated as a first line therapy for West syndrome and is not associated with serious adverse effects

    Determining the Optimal Dosage of Dexmedetomidine for Smooth Emergence in Older Patients Undergoing Spinal Surgery: A Study of 44 Cases

    Get PDF
    BACKGROUND Emergence agitation, or delirium, occurs during early recovery from general anesthesia and involves disorientation, excitation, and uncontrolled physical movements. Dexmedetomidine is an alpha agonist that has sedative, anxiolytic, analgesic, and sympatholytic activities and is used as a continuous infusion to prevent emergence agitation. This study aimed to evaluate patients aged 65 years and older undergoing general anesthesia to determine the 90% effective dose (ED90) of dexmedetomidine continuous intraoperative infusion to prevent emergence agitation. MATERIAL AND METHODS We enrolled 44 patients aged 65 years and older undergoing spinal surgery under general anesthesia. Dexmedetomidine administration commenced 30 minutes before surgery completion, with a predetermined infusion dose (ฮผg/kg/h), without a loading dose. The initial dose was 0.2 ฮผg/kg/h, and subsequent step size was ยฑ0.05 ฮผg/kg/h. We tried to find ED90 of dexmedetomidine using the biased-coin design. Vital signs, extubation quality scores, extubation-related complications, and postoperative outcomes were monitored. RESULTS Dexmedetomidine EDโ‚‰โ‚€ for smooth emergence in older patients was 0.34 ฮผg/kg/h. Peri-extubation vital signs remained within 20% of baseline values, without requiring pharmacological intervention. No hypoxia, hypoventilation, or post-extubation agitation occurred. In the recovery room, 1 patient briefly exhibited excitement but quickly calmed. Nine patients initially unresponsive in the recovery room fully awoke and were promptly discharged. CONCLUSIONS For older patients who are vulnerable to adverse effects of anesthetics and opioids, dexmedetomidine enables gentle awakening without adverse vital sign changes, respiratory depression, excessive sedation, or emergence agitation (EDโ‚‰โ‚€=0.34 ฮผg/kg/h). Further studies should involve a larger patient cohort, considering diverse medical conditions in older individuals

    Association Between Obstructive Sleep Apnea and Risk of Benign Vocal Fold Lesions: A Nationwide 9-Year Follow-Up Cohort Study

    Get PDF
    Since obstructive sleep apnea (OSA) affects various parts of the body, there has been little interest about the effect of OSA on voice. The objective of this study was to evaluate the risk of benign vocal fold lesions (BVFL) in OSA patients. This study used data from the National Health Insurance Service (NHIS) database. The study group was defined as the group diagnosed with OSA between 2008 and 2011. Non-OSA groups were selected based on propensity score (PS) matching. Incidence of BVFL among participants during the follow-up was analyzed. Cox proportional hazard regression analyses were performed to evaluate the association between OSA and incident BVFL. The HR value of the OSA group calculated by considering 8 variables indicates that the risk of developing BVFL is 79% higher than that of the control group. Further, among OSA patients, patients with a history of OP had a 35% lower risk of developing BVFL. The relationships between BVFL and 7 individual variables considered were as follows: For age, HR for the 40 to 59 years group was 1.20 (95%CI, 1.09-1.32). For sex, the HR in the female group was 1.22 (95%CI, 1.10-1.35). For residential areas, the HR values for Seoul 1.39 (95%CI, 1.23-1.59). In the high economic status group, the HR was 1.10 (95%CI, 1.01-1.21). This observational study indicated that OSA is associated with an increased incidence of BVFL. The incidence of BVFL increased with older age, female sex, and high SES
    • โ€ฆ
    corecore